Table 4.
Number | (%) | ||
---|---|---|---|
Cause of pain | |||
Tumor-related NP | 26 | 78.8 | |
Tumor infiltration or compression | 9 | 27.3 | |
Lumbosacral plexopathy | 7 | 21.2 | |
Cervical plexopathy | 3 | 9.1 | |
Brachial plexopathy | 3 | 9.1 | |
Other | 4 | 12.1 | |
Treatment-related NP | 6 | 18.2 | |
Chemotherapy and/or biologic treatment | 6 | 18.2 | |
Radiotherapy | 0 | 0 | |
Post-surgery neuralgia | 0 | 0 | |
Non-oncologic NP | 1 | 3.0 | |
Lumbar spinal stenosis | 1 | 3.0 | |
Postherpetic neuralgia | 0 | 0 | |
Primary tumor site | NP Pt/Cancer Pt (%) | ||
Lung | 5 | 15.2 | 5/13 (38.5) |
Stomach | 5 | 15.2 | 5/13 (38.5) |
Prostate | 4 | 12.1 | 4/4 (100.0) |
Breast | 2 | 6.1 | 2/5 (40.0) |
Colon–rectum | 2 | 6.1 | 2/14 (14.3) |
Uterus | 2 | 6.1 | 2/5 (40.0) |
Other | 13 | 39.4 |
NP, neuropathic pain; NP Pt/Cancer Pt, number of NP patients/number of cancer patients (for each cancer type).